AREDS 2 findings reported in JAMA 2013 suggested that:
- Lutein & Zeaxanthin could be an appropriate substitute for β-Carotene in the AREDS formulation
- Comparison of low-dose zinc vs high-dose zinc showed no evidence of a statistically significant effect
Responding to these findings, the MDeyes Once Daily formula delivers the specific ingredients and total daily amounts of the AREDS 2 low zinc trial.
MDeyes also features innovative packaging (design registration pending) to assist patients’ dosage compliance:
- Calendar labelling on the blister foil helps patients remember their daily capsule
- A grid on the back of the pack further supports daily compliance
Australian owned and made, MDeyes is an Eye Care Professional only brand.
It is priced affordably, and not sold through pharmacy.
For more information, contact Phasem Health Pty Ltd on 1300 95 2001 or [email protected]
